MYC and neoplasm: This generates a catalytically inactive enzyme (dCas9) that is linked either to a strong transcriptional activation domain (148) or to a transcriptional repressor domain (143), depending on whether a tumor-suppressive MYC target should be activated or an oncogenic MYC target downregulated.